AI-generated summary
This review discusses photobiomodulation (low-level laser therapy) for three types of alopecia: androgenetic, areata, and chemotherapy-induced. The authors summarize mechanisms of action, devices (mostly low-powered red laser diodes), dosimetry, animal models, clinical trials, and criteria for patient selection. The abstract does not report a pooled clinical outcome.
- Who or what was studied
- Patients with androgenetic alopecia, alopecia areata, or chemotherapy-induced alopecia
- Limits stated in the abstract
- The abstract does not state the number of studies or patients reviewed, nor any quality or certainty assessment of the included evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Low-level laser therapy, Dosimetry. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.